Original paper
Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis
Abstract
Objective Osteoclast‐mediated bone loss in the hand predicts future bone erosions in patients with rheumatoid arthritis (RA). Osteoclast activity depends on RANKL, which is inhibited by denosumab, an investigational fully human monoclonal antibody against RANKL. We measured metacarpal shaft cortical bone thickness using a novel computer‐based technique, digital x‐ray radiogrammetry (DXR), to evaluate the effects of denosumab on cortical bone in...
Paper Details
Title
Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis
Published Date
Mar 30, 2010
Journal
Volume
62
Issue
4
Pages
537 - 544
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History